Sep 20, 2018
Study: Immediate Compression Could Help Prevent Complications After Deep-Vein Thrombosis
Aug 26, 2018
Researcher finds new blood clot prevention strategy
Aug 10, 2018
Venous Thromboembolism Epidemiology Forecast In 24 Major Markets 2018-2028: Analysis & Forecasts Split by Gender and 5-Year Age Cohort
Jul 06, 2018
Thrombosis Drugs Market to be Worth US$ 47 Bn by 2026, Says TMR
Jun 14, 2018
XARELTO® (rivaroxaban) Associated with Significantly Reduced Time in Hospital and Decreased Costs Compared to Standard of Care in New Study of Patients with Low-Risk Pulmonary Embolism (PE)
May 21, 2018
FlowTriever System from Inari Medical Receives FDA 510(k) Clearance for Treatment of Pulmonary Embolism
Mar 06, 2018
Perioperative short haul air travel associated with increased risk of venous thromboembolism following lower limb arthroplasty
Feb 08, 2018
Global Unfractionated Heparin Market is Projected to Reach Valuation of US$1664.4 Million by 2025: Transparency Market Research
Dec 15, 2017
Once-Daily Oral Anticoagulant LIXIANA® (edoxaban) Met Primary Endpoint in Investigational Hokusai-VTE CANCER Study
Dec 12, 2017
Once-Daily, Oral SAVAYSA® (edoxaban) Met Primary Endpoint in Investigational Hokusai-VTE CANCER Study
Sep 21, 2017
ManaMed Inc. Introduces PlasmaFlow, The World's First FDA-Approved Digital and Tubeless Deep Vein Thrombosis Prevention Device
Jul 26, 2017
EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2026
Jun 29, 2017
ISTH 2017 Congress: Top Global Experts Convene in Berlin to Showcase Latest Research in Thrombosis, Hemostasis and Vascular Biology
Jun 28, 2017
U.S. FDA Grants Priority Review of XARELTO® (rivaroxaban) sNDA for a 10 mg Dose to Reduce the Risk of Recurrent Venous Thromboembolism (VTE)
Jun 24, 2017
European Hematology Association: Bleeding or Clotting in Elderly Patients with Cancer-Associated Venous Thromboembolism: Which is Worse?
Jun 22, 2017
Physician-Patient Alliance for Health & Safety Participates in 1st Annual Anticoagulation Summit